<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>T cell receptor signaling</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">T cell receptor signaling</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">T cell receptor signaling</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Chaim M Roifman, CM, MD, FRCPC, FCACB</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Luigi D Notarangelo, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth TePas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 08, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H11026511"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>T cell recognition of antigen forms the basis of adaptive T cell immunity. Antigen is digested into peptides and bound to major histocompatibility complex (MHC) on the surface of antigen presenting cells (APCs) for presentation to T cells. Recognition of self and foreign peptides by T cell receptor (TCR) complexes on immature thymocytes and mature T cells is necessary for the positive and negative selection of developing thymocytes and the functional responses of T cells. This topic briefly reviews signaling through the TCR complex, identifying the proteins involved and highlighting downstream targets of the signaling cascade.</p><p>TCR genetics, structure, and biology are covered in detail separately. (See  <a class="medical medical_review" href="/d/html/3950.html" rel="external">"T-B-NK+ SCID: Pathogenesis, clinical manifestations, and diagnosis", section on 'T cell receptor generation'</a> and  <a class="medical medical_review" href="/d/html/3980.html" rel="external">"The adaptive cellular immune response: T cells and cytokines", section on 'T cell activation and functions'</a> and  <a class="medical medical_review" href="/d/html/3956.html" rel="external">"CD3/T cell receptor complex disorders causing immunodeficiency", section on 'Overview of T cell receptor biology'</a>.)</p><p>Reviews related to combined immunodeficiencies caused by defects in TCR complex molecules are also presented separately. (See  <a class="medical medical_review" href="/d/html/3956.html" rel="external">"CD3/T cell receptor complex disorders causing immunodeficiency"</a> and  <a class="medical medical_review" href="/d/html/3935.html" rel="external">"Combined immunodeficiencies: An overview"</a> and  <a class="medical medical_review" href="/d/html/3940.html" rel="external">"ZAP-70 deficiency"</a>.)</p><p class="headingAnchor" id="H11026518"><span class="h1">BRIEF OVERVIEW OF THE SIGNALING CASCADE</span><span class="headingEndMark"> — </span>TCR signaling in naïve T cells is initiated by TCR binding to peptide major histocompatibility complex (pMHC) complexes on the surface of antigen presenting cells (APCs). This engagement leads to a series of intracellular signaling events that culminate in the generation of a T cell response (<a class="graphic graphic_figure graphicRef66727" href="/d/graphic/66727.html" rel="external">figure 1</a>) [<a href="#rid1">1-6</a>].</p><p>The Src-family protein tyrosine kinase Lck is first activated with resultant phosphorylation of CD3 coreceptor cytoplasmic domains, specifically at motifs known as immunoreceptor tyrosine-based activation motifs (ITAMs). These phosphorylated ITAMs on CD3-zeta serve as binding sites for the zeta chain-associated protein kinase, ZAP-70. ZAP-70 is activated by Lck-mediated phosphorylation and subsequent autophosphorylation. Activated ZAP-70 then phosphorylates a variety of linker/adapter proteins, such as linker for activation of T cells (LAT) and Src-homology 2 domain-containing 76-kDa leukocyte protein (SLP-76). Further signaling proteins are then recruited, resulting in calcium mobilization, actin cytoskeleton reorganization, and activation of Ras guanosine triphosphate hydrolases (GTPases).</p><p>Downstream from these events, there is activation of transcription factors, such as nuclear factor of activated T cells (NF-AT), activator protein 1 (AP-1), and nuclear factor kappa light-chain enhancer of activated B cells (NF-kappa-B), with resultant alterations in the pattern of T cell gene expression, proliferation, and differentiation of effector function.</p><p class="headingAnchor" id="H11026525"><span class="h1">EARLY SIGNAL TRANSDUCTION</span><span class="headingEndMark"> — </span>The TCR is a heterodimer, with approximately 95 percent of peripheral blood T cells expressing an alpha and a beta chain. The alpha and beta chains of the TCR lack substantial cytoplasmic extensions and communicate with the interior of the cell through association with a group of single-span transmembrane proteins known as the CD3 family. CD3 gamma, delta, epsilon, and zeta form a complex with the TCR-alpha-beta receptor in a 1:1:2:2 ratio, respectively, for each TCR. In contrast to the TCR alpha and beta chains, the CD3 family members possess no known extracellular ligand-binding capacity, but have long cytoplasmic tails that serve as frameworks for intracellular signaling. The antigen-bound TCR/CD3 complex lacks intrinsic catalytic activity, and, therefore, initiation of signal transduction is critically dependent upon the activity of two protein tyrosine kinases: Lck and ZAP-70 (<a class="graphic graphic_figure graphicRef62164" href="/d/graphic/62164.html" rel="external">figure 2</a> and <a class="graphic graphic_figure graphicRef66727" href="/d/graphic/66727.html" rel="external">figure 1</a>) [<a href="#rid7">7-15</a>].</p><p>Failure to express any member of the CD3 family results in some degree of immunodeficiency, often severe. CD3-gamma-deficient patients typically have near-normal T cell numbers, although with reduced TCR/CD3 complex expression, and show mild immunodeficiency. In contrast, complete CD3-epsilon, CD3-delta, and CD3-zeta deficiencies typically display a T-B+(natural killer [NK]+) severe combined immunodeficiency (SCID). These all appear to result from an early block in T cell development. Partial deficiencies in expression of individual CD3 chains have been reported, typically with less severe immunodeficiency. NK cytotoxic function is also altered in CD3-zeta deficiency. (See  <a class="medical medical_review" href="/d/html/3956.html" rel="external">"CD3/T cell receptor complex disorders causing immunodeficiency", section on 'CD3 deficiency'</a> and  <a class="medical medical_review" href="/d/html/3912.html" rel="external">"Severe combined immunodeficiency (SCID): Specific defects", section on 'CD3 complex component deficiencies'</a>.)</p><p class="headingAnchor" id="H11026532"><span class="h2">Lck</span><span class="headingEndMark"> — </span>Lck is a 56-kDa member of the Src-family tyrosine kinase family that is found constitutively associated with the cytoplasmic domain of the TCR coreceptors, CD4 and CD8 (<a class="graphic graphic_figure graphicRef66727" href="/d/graphic/66727.html" rel="external">figure 1</a>). It is activated rapidly following antigen binding to the TCR. Lck activity is absolutely required for normal T cell development and function.</p><p>Lck has two critically important roles in the initiation of TCR signaling. The first is phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) present in the cytoplasmic domains of the CD3 chains. These mediate interaction with other kinases (eg, CD3-epsilon ITAM binds the Src-family kinase Fyn, while ZAP-70 binds CD3-zeta) [<a href="#rid16">16-22</a>]. The second is phosphorylation of ZAP-70 on multiple residues subsequent to its recruitment to phosphorylated CD3-zeta chains, inducing activation of ZAP-70 [<a href="#rid16">16,21-23</a>]. In addition to its initiatory role in TCR signaling, Lck also has other functions further downstream in the signaling pathway (eg, phosphorylation of the Emt/Itk kinase).</p><p>Deficiency of Lck is reported to result in an immunodeficiency characterized by selective CD4 lymphopenia. Patients demonstrate the typical failure to thrive seen in SCID, opportunistic infections, and low to absent immunoglobulins. (See  <a class="medical medical_review" href="/d/html/3956.html" rel="external">"CD3/T cell receptor complex disorders causing immunodeficiency", section on 'Lck deficiency'</a> and  <a class="medical medical_review" href="/d/html/3917.html" rel="external">"Idiopathic CD4+ lymphocytopenia"</a>.)</p><p>The Lck protein is composed of a catalytic protein tyrosine kinase domain, a Src-homology 2 (SH2) domain that recognizes phosphorylated tyrosine residues in the general context TyrXXLeu, and a Src-homology 3 (SH3) domain that can bind proline rich motifs, generally with the pattern ProXProXXPro (where X equals any amino acid). Lck undergoes lipid modification during synthesis, with N-terminal myristoylation anchoring it to the inner leaflet of the T cell plasma membrane.</p><p>There are two main tyrosine phosphorylation sites on Lck itself, residues 394 and 505. Tyr394 is an autophosphorylation site on the activation loop of the Lck catalytic domain, (Tyr394 phosphorylation results in Lck activation). Phosphorylation of the activation loop causes it to be repelled from the mouth of the catalytic site, enhancing substrate access. In contrast, Tyr505 undergoes negative regulatory phosphorylation by the c-Src kinase (Csk), leading to a "closed" conformation of Lck. The phosphorylated residue is bound by the Lck SH2 domain, folding up the protein into a conformation that blocks substrate access to the active site.</p><p>The interplay between Tyr394 and Tyr505 phosphorylation in regulating Lck catalytic activity is complex. Modification of Tyr505 alone is insufficient to turn off Lck. Rather, phosphorylation of Tyr505 appears to merely shift the dynamic equilibrium between an open and closed conformation to favor more time spent in the closed state. Dephosphorylation of Tyr394 must also occur to completely downregulate Lck catalytic activity. To this end, the tyrosine phosphatase PTPN22 [<a href="#rid24">24</a>] is believed to act in a complex with Csk to regulate Lck (and other Src-kinase family members). A variant allele of the PTPN22 phosphatase encoding an arginine to tryptophan alteration (R620W), relatively common in the White population, is linked to increased susceptibility to the development of autoimmunity [<a href="#rid25">25-28</a>]. The R620W allele of PTPN22 is a reported gain-of-function variant with increased catalytic activity that accelerates the downregulation of Lck activity subsequent to engagement of the TCR [<a href="#rid25">25-30</a>].</p><p>Furthering the regulation of early signaling events, a transmembrane adaptor protein phosphoprotein associated with glycosphingolipid microdomains (PAG/Cbp) is basally tyrosine phosphorylated in resting human T cells and subsequently bound by the SH2 domain of Csk, maintaining Csk at the plasma membrane. PAG/Cbp undergoes rapid dephosphorylation following TCR stimulation, with accompanying loss of Csk binding and recruitment to the membrane, permitting TCR signaling to proceed. Overexpression of PAG inhibits TCR-mediated responses. Cbp phosphorylation is regulated by the Src-kinase family member Fyn [<a href="#rid31">31,32</a>].</p><p>Early models of TCR signaling suggested that Lck was activated by interaction with the receptor tyrosine phosphatase CD45 following TCR recognition of antigen/major histocompatibility complex (MHC), removing negative regulatory phosphorylation from the kinase. However, subsequent findings suggest that a large percentage of thymocytes and resting T cells already contain a large pool of preactivated Lck, priming them for a rapid response. Conformational changes releasing constraints on Lck, or changes promoting Lck interaction with CD3 cytoplasmic domains, are now believed to initiate signal transduction. Studies demonstrate a close electrostatic-based interaction between the unactivated CD3-epsilon cytoplasmic domain and the inner leaflet of the plasma membrane, resulting in the insertion of key tyrosines into the lipid bilayer, potentially segregating them from Lck [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H11026539"><span class="h2">ZAP-70</span><span class="headingEndMark"> — </span>An appreciation of the role of ZAP-70 in the biology of T cells and in TCR signaling came first from the description of a human deficiency of ZAP-70. This deficiency results in an unusual combined immunodeficiency where normal CD4+ T cells counts are present in the periphery, but CD8+ T cells are absent [<a href="#rid34">34,35</a>]. ZAP-70-deficient thymi have normal architecture, but single-positive CD8+ cells are absent from the medulla [<a href="#rid36">36</a>] due to a block between double-negative and double-positive cells [<a href="#rid37">37</a>]. CD4+ peripheral T cells are nonfunctional, and patients require hematopoietic stem cell replacement (ie, transplantation) to generate a functional T cell pool. (See  <a class="medical medical_review" href="/d/html/3940.html" rel="external">"ZAP-70 deficiency"</a>.)</p><p>The ZAP-70 tyrosine kinase is recruited to the TCR complex following ITAM phosphorylation of the CD3-zeta chain by Lck [<a href="#rid19">19,20,38-41</a>]. ZAP-70 possesses tandem SH2 domains that bind the phosphorylated CD3-zeta ITAM motif. ITAMs are four amino acid SH2 domain binding sequences, YXX(L/V) that occur as a pair and are separated by a six to nine residue spacer region. Two SH2 domains were predicted in the ZAP-70 structure, but radiograph crystallographic analysis demonstrated that only one of these bound in the predicted manner, forming a specific pocket to enclose one of the phosphorylated tyrosine residues of CD3-zeta [<a href="#rid42">42</a>]. The second ZAP-70 SH2 domain formed an incomplete pocket, with atypical binding of the second phosphorylated tyrosine observed [<a href="#rid41">41</a>].</p><p>Following binding to CD3-zeta, ZAP-70 undergoes phosphorylation at specific tyrosine residues, primarily by Lck, but also as the result of transautophosphorylation [<a href="#rid38">38,43-46</a>]. Much of the increase in ZAP-70 kinase activity following TCR stimulation is associated with the specific phosphorylation of Tyr493 in the activation loop of the ZAP-70 catalytic domain [<a href="#rid43">43-46</a>], although the act of binding CD3-zeta also causes conformational changes that increase activity. Binding to the phosphorylated CD3-zeta ITAM may further serve to fully expose Lck regulatory phosphorylation sites.</p><p>Phosphorylation of Tyr315 and Tyr319 within ZAP-70 also promotes TCR signal transduction by functioning as binding sites for downstream molecules: Tyr315 for the Vav guanine nucleotide exchange factor [<a href="#rid47">47-49</a>] and Tyr 319 for phospholipase Cγ 1 [<a href="#rid47">47,50-52</a>], presumably directing access for their phosphorylation by the ZAP-70 kinase domain.</p><p>ZAP-70 enzymatic activity is also negatively regulated by phosphorylation at Tyr492 [<a href="#rid43">43,44,53</a>]. Furthermore, phosphorylation of Tyr292 has been shown to downregulate ZAP-70 function by serving as a binding site for the ubiquitin ligase, Cbl. The E3-ubiquitin ligase Cbl modifies ZAP-70 through ubiquitylation of lysine residues, targeting it for proteasomal degradation [<a href="#rid54">54,55</a>]. Cbl negatively regulates the activation of a number of TCR signal transducing proteins by inducing their degradation. ZAP-70 activity also appears to be downregulated as a result of the removal of activating tyrosine phosphorylation by cytoplasmic tyrosine phosphatases, including PTPN22 [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H11026546"><span class="h1">DISTAL CASCADE</span><span class="headingEndMark"> — </span>Engagement of the TCR/CD3 complex by peptide major histocompatibility complex (pMHC) and subsequent activation of Lck and ZAP-70 kinases trigger a signaling cascade within the cell. This cascade culminates in the activation of pathways inducing transcription factor activity, with subsequent proliferation, differentiation, and cytokine secretion (<a class="graphic graphic_figure graphicRef66727" href="/d/graphic/66727.html" rel="external">figure 1</a>).</p><p>The three major enzymatic pathways activated by TCR ligation are the mitogen-activated protein kinases (MAPK), the Rho family guanosine triphosphate hydrolases (GTPases), and phosphoinositol-regulated pathways. These pathways send signals into the nucleus via transcription factors, such as activator protein 1 (AP-1, dimer of Jun and Fos) and the nuclear factor of activated T cells (NF-AT).</p><p>The downstream interactions result in signal amplification and culminate in the transcription of genes required for T cell activation and initiation of T cell-specific responses, such as CD69 upregulation and interleukin-2 (IL-2) secretion in mature naïve T cells. The molecules and processes involved in the subsequent downstream cascade continue to be identified.</p><p>ZAP-70-mediated tyrosine phosphorylation events are required for the mobilization of intracellular free calcium ([Ca<sup>2</sup>+]i) [<a href="#rid34">34</a>] and activation of the Ras/MAPK and phosphatidylinositol-3 (PI-3) kinase pathways [<a href="#rid56">56-63</a>]. Specific substrates for ZAP-70 include the adaptor proteins linker for activation of T cells (LAT) and Src-homology 2 (SH2) domain-containing 76-kDa leukocyte protein (SLP-76) [<a href="#rid9">9-13,51,56-61,64</a>]. Additional molecules that are recruited to the TCR via interactions with ZAP-70 or ZAP-70 substrates include Cbl, Vav, Grb-2, Sos, Gads, Itk, Ras-GTPase activating protein (GAP), and the p85 subunit of PI-3 kinase [<a href="#rid9">9-13,38,48,49,56-62,65</a>].</p><p class="headingAnchor" id="H11026553"><span class="h2">LAT</span><span class="headingEndMark"> — </span>ZAP-70 efficiently phosphorylates the integral membrane adaptor protein LAT. Phosphorylated LAT acts as a scaffold, promoting the interaction of a number of signal transducing proteins including the adaptor Grb2-related adaptor protein-2 (GRAP2/Gads), SLP-76, IL-2 inducible T cell kinase (ITK), Grb2, p85 PI-3 kinase and phospholipase C gamma 1 (PLC-gamma-1). T cell development does not proceed beyond the earliest stages in the absence of LAT [<a href="#rid66">66,67</a>]. Palmitoylation during synthesis sequesters LAT into the lipid raft compartment of the plasma membrane.</p><p>Grb2 binding to LAT serves to recruit Son of Sevenless (SOS), a guanine nucleotide exchange factor for the small GTPase Ras, leading to the activation of Ras and the MAPK cascade, with important roles in cellular activation and regulation of the cell cycle. The Ras guanyl nucleotide-releasing protein (RasGRP) is also recruited to the plasma membrane upon generation of diacylglycerol (DAG) and activated by protein kinase C (PKC)-theta-mediated serine phosphorylation.</p><p>SLP-76 is also an adaptor protein, recruiting ITK, Gads, Vav, and Nck to the LAT signalosome. In association with Vav, SLP-76 and LAT lead to activation of the Rho family of small GTPases, cdc42 and Rac1. These function in cytoskeletal reorganization. SLP-76 and LAT also link the TCR to activation of PI-3 kinase. PI3-kinase modifies membrane phosphatidylinositol (PtdIns) lipids, phosphorylating the 3' position hydroxyl group of the inositol ring.</p><p class="headingAnchor" id="H11026560"><span class="h2">Lipid and lipid derived messengers</span><span class="headingEndMark"> — </span>Generation of 3'-phosphorylated-inositol lipids in the plasma membrane can create binding sites for signaling molecules possessing a PtdIns-binding pleckstrin homology (PH) domain, including the cytoplasmic expressed in mast and T cells/IL-2-inducible T cell tyrosine kinase (Emt/Itk) that is recruited to the membrane following TCR activation. Emt/Itk also binds the membrane adapter LAT via its SH2 domain, after phosphorylation of LAT by ZAP-70. Emt/Itk is subsequently activated via Lck-mediated tyrosine phosphorylation. Emt/Itk-deficient mice display compromised PLC-gamma-1 phosphorylation and reduced extracellular calcium flux in response to TCR stimulation [<a href="#rid68">68-72</a>].</p><p>PI3-kinase activity is also responsible for PH domain-dependent recruitment of PLC-gamma-1 in response to TCR engagement through the generation of phosphatidylinositol(3,4,5)trisphosphate in the plasma membrane. SLP-76 and LAT also link to the PLC-gamma-1 pathway. PH domain-mediated docking to the plasma membrane also recruits 3-phosphoinositide-dependent protein kinase 1 (PDPK1) and its substrate Akt (also called protein kinase B,PKB), activating this survival promoting pathway [<a href="#rid73">73,74</a>].</p><p>PLC-gamma-1 cleaves phosphatidylinositol(4,5)bisphosphate into DAG and inositol triphosphate (IP3). Membrane-bound DAG activates members of the PKC family, in particular PKC-theta, which plays important roles in activation of Ras and the transcription factor nuclear factor kappa light-chain enhancer of activated B cells (NF-kappa-B). In unstimulated cells, NF-kappa-B is sequestered to the cytoplasm by interaction with the inhibitor of kappa-B (I-kappa-B). NF-kappa-B activation requires I-kappa-B degradation. In a signal cascade, DAG-activated PKC-theta phosphorylates the I-kappa-B kinase IKK, which in turn phosphorylates I-kappa-B, causing its ubiquitination and subsequent degradation, freeing NF-kappa-B to translocate into the nucleus. DAG also recruits Ras guanyl nucleotide-releasing protein (RasGRP) to the membrane where the guanine release factor undergoes PKC-theta-mediated activating phosphorylation and helps activate the Ras signaling pathway.</p><p>Soluble IP3 mobilizes calcium from intracellular storage sites by binding to IP3 receptors on the surface of the endoplasmic reticulum (ER).</p><p class="headingAnchor" id="H11026567"><span class="h2">Calcium</span><span class="headingEndMark"> — </span>Sustained elevation of cytosolic levels of free calcium (Ca<sup>2</sup>+) plays a critical role in promoting TCR signaling. Several hours of Ca<sup>2</sup>+ influx are required to complete T cell activation. In particular, elevated Ca<sup>2</sup>+ maintains prolonged nuclear accumulation of NF-AT by activating the phosphatase calcineurin, which dephosphorylates the cytoplasmic form of the transcription factor NF-AT, allowing it to enter the nucleus and initiate transcription.</p><p>Store-operated Ca<sup>2</sup>+ entry is used by many types of cells, including lymphocytes, to increase intracellular Ca<sup>2</sup>+ concentrations to initiate signal transduction [<a href="#rid75">75</a>]. Activation of the TCR results in an IP3-dependent release of Ca<sup>2</sup>+ ions from ER Ca<sup>2</sup>+ stores. Depletion of Ca<sup>2</sup>+ from this internal store subsequently leads to the opening of plasma membrane ion channels allowing an influx of external Ca<sup>2</sup>+.</p><p>Stromal interaction molecule 1 (STIM1) expressed in the ER senses ER calcium ion levels and is responsible for triggering Ca<sup>2</sup>+ release-activated Ca<sup>2</sup>+ (CRAC) channels. Patients with STIM1 mutations abrogating STIM1 expression (and subsequently Ca<sup>2</sup>+ influx) present with many immune defects, including immunodeficiency, hepatosplenomegaly, autoimmune hemolytic anemia, and thrombocytopenia. Studies of STIM1-deficient mice suggest that STIM1-dependent store-operated Ca<sup>2</sup>+ entry is critical for homeostatic T cell proliferation but less important for T cell differentiation or effector function [<a href="#rid76">76</a>]. (See  <a class="medical medical_review" href="/d/html/3951.html" rel="external">"Syndromic immunodeficiencies"</a>.)</p><p>Mutations in <em>ORAI1</em>, the gene encoding the pore-forming subunit of the CRAC channel, abrogate the store-operated entry of Ca<sup>2</sup>+ into cells and also impair lymphocyte activation. In humans, ORAI1 deficiency presents with normal lymphocyte counts and serum immunoglobulin levels but is characterized by recurrent infections, impaired T cell activation and proliferative responses, and decreased production of cytokines. (See  <a class="medical medical_review" href="/d/html/3951.html" rel="external">"Syndromic immunodeficiencies"</a>.)</p><p class="headingAnchor" id="H11026574"><span class="h2">Actin</span><span class="headingEndMark"> — </span>Activation of the Vav/Rho family signaling pathway leading to rearrangement of the actin cytoskeleton plays a critical role in sustaining the T cell signaling response. TCR activation typically occurs upon encounter with antigen-loaded MHC on antigen presenting cells (APCs). At this point, the T cell undergoes a transition from a highly motile cell in an APC scanning mode to one favoring relatively stable interactions. TCR engagement leads to the rapid formation of filamentous actin, required for polarization or reorientation of the T cell towards the stimulating cell [<a href="#rid77">77</a>].</p><p>Effective T cell response appears dependent upon the formation of a highly spatially ordered interface between the T cell and APC referred to as the immunologic synapse (IS) or supramolecular activation cluster (SMAC) [<a href="#rid78">78-80</a>]. This structure is composed of concentric rings each containing specific receptors and signaling proteins. As examples, the TCR/CD3 complex and associated signaling proteins cluster into a "central supramolecular activation cluster" (c-SMAC), while lymphocyte function-associated antigen 1 (LFA-1) integrin is found in a peripheral SMAC (p-SMAC) that forms a ring of adhesion between the cells. The maintenance of an intact IS for many hours appears to be required for the effective activation of the T cell, although the identity of the particular APC (eg, dendritic cell, macrophage, B cell) may significantly affect requirements. The stable synapse may also provide a focal point for focused secretion and endocytosis. (See  <a class="medical medical_review" href="/d/html/3982.html" rel="external">"Antigen-presenting cells"</a>.)</p><p>TCR signaling-induced rearrangement of the actin cytoskeleton plays a critical role in decreasing T cell motility, in the molecular segregation of the T cell surface receptors, and in spatial organization of intracellular signaling components. Even prior to the formation of the mature IS, activated TCR/CD3 complexes form microclusters that localize into the c-SMAC in a process dependent upon actin polymerization. Thus, early signaling events prepare the platform for sustained distal signaling and T cell responses. Evidence suggests that the c-SMAC have an active TCR signaling zone and a TCR downregulating zone that uses ubiquitination machinery. PKC-theta and Wiskott–Aldrich syndrome protein (WASp) activity critically regulate synapse stability. Immunologic synapses are hyperstable in PKC-theta-deficient T cells, while they are unstable in WASp-deficient cells [<a href="#rid81">81</a>].</p><p>Wiskott–Aldrich syndrome, or WASp deficiency, is an X-linked immunodeficiency in humans characterized by increased susceptibility to infections, eczema, thrombocytopenia, and decreased antibody production. Patients also display autoimmune disease and an increased incidence of malignancy, although the type of <em>WAS</em> mutation correlates significantly with the degree of disease severity. WASp-deficient T cells show impaired proliferation and actin rearrangement. (See  <a class="medical medical_review" href="/d/html/3953.html" rel="external">"Wiskott-Aldrich syndrome"</a>.)</p><p>TCR-mediated activation of T cell adhesion molecules such as LFA-1 is also critical to IS formation. The mechanism by which inside-out signaling to activate LFA-1 operates is unclear but involves activation of the Rac GTP exchange factor (GEF) Vav and the Rap1 GEF, C3G. Rap1 may be recruited to the plasma membrane by the adhesion and degranulation-promoting adaptor protein/Src kinase-associated phosphoprotein of 55 kDa (ADAP/SKAP55) adapter protein complex.</p><p>For a more detailed review of TCR signaling kinetics at the synapse, see [<a href="#rid82">82</a>].</p><p class="headingAnchor" id="H11026581"><span class="h1">TCR SIGNALING IN T CELL ONTOGENY</span><span class="headingEndMark"> — </span>The TCR/CD3 complex is not only absolutely required for the proper function of mature T cells, but also plays a significant role in T cell ontogeny (<a class="graphic graphic_figure graphicRef76102" href="/d/graphic/76102.html" rel="external">figure 3</a>). (See  <a class="medical medical_review" href="/d/html/13933.html" rel="external">"Normal B and T lymphocyte development"</a>.)</p><p>Early in the differentiation of the thymocyte, genomic DNA encoding one of the TCR-beta chains undergoes physical rearrangement to create a functional gene in a process known as V(D)J recombination (somatic recombination of the variable, diverse, and joining gene segments). This is dependent upon recombinase-activating genes 1 and 2 (<em>RAG1</em> and <em>RAG2</em>) [<a href="#rid1">1,2</a>]. Failure to correctly rearrange the TCR-beta locus as a result of defective RAG enzyme activity results in severe combined immunodeficiency (SCID) that often presents as Omenn syndrome [<a href="#rid83">83</a>]. (See  <a class="medical medical_review" href="/d/html/3950.html" rel="external">"T-B-NK+ SCID: Pathogenesis, clinical manifestations, and diagnosis"</a>.)</p><p>The differentiating thymocyte identifies functional rearrangement of the TCR-beta gene by its ability to signal. The rearranged TCR-beta chain associates with an invariant pre-TCR-alpha (pT-alpha) chain to form an active pre-TCR complex with CD3 chains that is hypothesized to signal in a nonligand-dependent manner. This may be due to a high potential for self-multimerization, conferring autonomous signaling [<a href="#rid84">84,85</a>]. Signaling through the pre-TCR complex involves many of the same proteins critical to mature TCR signaling including ZAP-70, linker for activation of T cells (LAT), Lck, Fyn, and phospholipase C gamma 1 (PLC-gamma-1), although their relative importance may vary [<a href="#rid86">86-89</a>]. Pre-TCR signals promote thymocyte survival and proliferation, expression of CD4 and CD8 coreceptors, rearrangement of TCR-alpha, and also induce a process known as allelic exclusion, whereby rearrangement of the second TCR-beta allele is prevented. (See  <a class="medical medical_review" href="/d/html/3950.html" rel="external">"T-B-NK+ SCID: Pathogenesis, clinical manifestations, and diagnosis", section on 'T cell receptor generation'</a>.)</p><p>T cell precursors in the thymus with correctly rearranged TCR alpha and beta chains undergo positive and negative selection processes before they mature into CD4+ or CD8+ T cells [<a href="#rid90">90</a>]. The fate of these cells is determined in large part by the interaction of the TCR/CD3 complex with self-antigens presented by thymic epithelial cells. Strong interaction and, as a result, a prolonged/high level of TCR signaling in the thymocyte indicates that there is the potential for autoreactivity, and these cells are deleted (negative selection). A weak to moderate interaction between the thymocyte and self-antigen presenting epithelial cells allows the cells to mature (positive selection). Levels of phosphorylated (activated) ZAP-70 and mitogen-activated protein kinase (MAPK) activation have been identified as critical signaling events linked to the selection process. (See  <a class="medical medical_review" href="/d/html/13933.html" rel="external">"Normal B and T lymphocyte development"</a>.)</p><p>CD3 or TCR chain deficiency may prevent the proper interaction of the precursors with the thymic epithelium, therefore eliminating the selection process. (See  <a class="medical medical_review" href="/d/html/3956.html" rel="external">"CD3/T cell receptor complex disorders causing immunodeficiency"</a>.)</p><p>A failure to negatively select or delete self-recognizing cells because of failure to express self-antigens in the thymus results in multisystem autoimmunity, as observed in autoimmune regulator (AIRE) transcription factor deficiency that causes autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) [<a href="#rid91">91,92</a>]. (See  <a class="medical medical_review" href="/d/html/13569.html" rel="external">"Chronic mucocutaneous candidiasis", section on 'Autoimmune regulator deficiency'</a>.)</p><p class="headingAnchor" id="H11026588"><span class="h2">Syk</span><span class="headingEndMark"> — </span>Syk is a 72-kDa molecule with significant homology to ZAP-70. Expressed predominantly in B cells and myeloid cells, Syk is also found in thymocytes and at low levels in some mature T cells [<a href="#rid93">93</a>]. It is critical to B cell receptor (BCR) signaling and functions in B cells in a manner fairly analogous to ZAP-70 in T cells. In murine thymocytes, Syk plays a role in TCR signaling. Syk binds phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs) and can be activated by pre-TCR and TCR stimulation [<a href="#rid8">8,16,94</a>]. Analysis of mice deficient in both Syk and ZAP-70 demonstrated that Syk is critical to early pre-TCR signaling in CD4- CD8- double-negative thymocytes and may induce ZAP-70 expression required for subsequent thymocyte selection [<a href="#rid86">86-88,95-97</a>]. (See  <a class="medical medical_review" href="/d/html/3940.html" rel="external">"ZAP-70 deficiency"</a>.)</p><p class="headingAnchor" id="H11026595"><span class="h2">Themis</span><span class="headingEndMark"> — </span>Thymocyte-expressed molecule involved in selection (Themis) is a protein of unknown function that is highly conserved among vertebrates. It is highly expressed in thymocytes between the pre-T cell antigen receptor and positive-selection checkpoints, with lower expression in mature T cells. Themis-deficient mice have few thymocytes, with a defect in positive selection, resulting in fewer mature thymocytes. Themis undergoes rapid tyrosine phosphorylation that is dependent upon LAT and Src-homology 2 domain-containing 76-kDa leukocyte protein (SLP-76) and interacts with LAT, PLC-gamma-1, Grb2 and inducible T cell kinase (ITK). The precise role of Themis in TCR signaling is still unclear, but T cells lacking <em>THEMIS</em> gene expression demonstrate reduced interleukin-2 (IL-2) expression following TCR stimulation as a result of reduced extracellular signal-regulated kinases (ERK) and nuclear factor of activated T cells (NF-AT)/activator protein 1 (AP-1) signaling. Evidence suggests that Themis is required for optimal calcium mobilization and MAPK activation [<a href="#rid84">84,98,99</a>].</p><p class="headingAnchor" id="H11026602"><span class="h1">NATURAL KILLER CELL SIGNALING</span><span class="headingEndMark"> — </span>As in T cells, some of the activating receptors expressed by natural killer (NK) cells possess immunoreceptor tyrosine-based activation motifs (ITAMs) that, when phosphorylated, can recruit ZAP-70 or Syk kinases to the plasma membrane for initiation of downstream signaling events [<a href="#rid85">85,100,101</a>]. ZAP-70 function is not absolutely required for human NK cell differentiation or cytotoxicity in vivo, unlike T cell ontogeny [<a href="#rid85">85,100,102</a>]. However, Syk may be critical for NK function, at least in humans [<a href="#rid100">100,101</a>]. (See  <a class="medical medical_review" href="/d/html/3940.html" rel="external">"ZAP-70 deficiency", section on 'Pathogenesis'</a> and  <a class="medical medical_review" href="/d/html/3949.html" rel="external">"NK cell deficiency syndromes: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3922.html" rel="external">"NK cell deficiency syndromes: Treatment"</a>.)</p><p class="headingAnchor" id="H11026609"><span class="h1">CORECEPTORS</span><span class="headingEndMark"> — </span>Although not discussed above, the coligation or activation of TCR coreceptors such as CD4, CD8, CD28, cytotoxic T-lymphocyte antigen 4 (CTLA-4), and other receptors, such as lymphocyte function-associated antigen 1 (LFA-1), can dramatically affect the final outcome of the TCR signaling cascade through the ability of these receptors to reinforce or inhibit the activation of signal transducing proteins in specific pathways [<a href="#rid103">103</a>]. (See  <a class="medical medical_review" href="/d/html/13933.html" rel="external">"Normal B and T lymphocyte development"</a> and  <a class="medical medical_review" href="/d/html/3980.html" rel="external">"The adaptive cellular immune response: T cells and cytokines"</a>.)</p><p class="headingAnchor" id="H11026616"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>Engagement of the T cell receptor (TCR) with peptide bound to the major histocompatability complex (MHC) expressed on antigen presenting cells (APCs) leads to a series of events that culminate in the generation of T cell responses (<a class="graphic graphic_figure graphicRef66727" href="/d/graphic/66727.html" rel="external">figure 1</a>). (See <a class="local">'Introduction'</a> above and <a class="local">'Brief overview of the signaling cascade'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Initial transduction of antigen-binding signals from the TCR/CD3 complex is primarily dependent upon two protein tyrosine kinases: Lck and ZAP-70 (<a class="graphic graphic_figure graphicRef66727" href="/d/graphic/66727.html" rel="external">figure 1</a>). (See <a class="local">'Early signal transduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Activation of early signaling molecules triggers a distal cascade in the cell, culminating in the activation of pathways that induce transcription factors, with subsequent proliferation, differentiation, and cytokine secretion responses. Three main pathways activated by T cell ligation are the mitogen-activated protein kinases (MAPK), the Rho family guanosine triphosphate hydrolases (GTPases), and phosphoinositol-regulated pathways. (See <a class="local">'Distal cascade'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The TCR/CD3 complex is mandatory for the proper function of mature T cells and also plays a significant role in T cell ontogeny (<a class="graphic graphic_figure graphicRef76102" href="/d/graphic/76102.html" rel="external">figure 3</a>). The processes involved in CD4 versus CD8 selection during T cell ontogeny require signal transduction through the pre-TCR and TCR of the differentiating thymocyte. The signaling events mediated by the pre-TCR and TCR on thymocytes are similar to those responsible for the activation of mature T cells. (See <a class="local">'TCR signaling in T cell ontogeny'</a> above and  <a class="medical medical_review" href="/d/html/13933.html" rel="external">"Normal B and T lymphocyte development"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ZAP-70 function is not absolutely required for natural killer (NK) cell differentiation or cytotoxicity. However, Syk may be critical for NK function. (See <a class="local">'Natural killer cell signaling'</a> above.)</p><p></p><p class="headingAnchor" id="H318008722"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges E Richard Stiehm, MD, who contributed as a Section Editor to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Love PE, Hayes SM. ITAM-mediated signaling by the T-cell antigen receptor. Cold Spring Harb Perspect Biol 2010; 2:a002485.</a></li><li><a class="nounderline abstract_t">Abraham RT, Weiss A. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat Rev Immunol 2004; 4:301.</a></li><li><a class="nounderline abstract_t">Huang Y, Wange RL. T cell receptor signaling: beyond complex complexes. J Biol Chem 2004; 279:28827.</a></li><li><a class="nounderline abstract_t">Gascoigne NR, Rybakin V, Acuto O, Brzostek J. TCR Signal Strength and T Cell Development. Annu Rev Cell Dev Biol 2016; 32:327.</a></li><li><a class="nounderline abstract_t">Singh NK, Riley TP, Baker SCB, et al. Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes. J Immunol 2017; 199:2203.</a></li><li><a class="nounderline abstract_t">Shah K, Al-Haidari A, Sun J, Kazi JU. T cell receptor (TCR) signaling in health and disease. Signal Transduct Target Ther 2021; 6:412.</a></li><li><a class="nounderline abstract_t">Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994; 76:263.</a></li><li><a class="nounderline abstract_t">Cheng AM, Chan AC. Protein tyrosine kinases in thymocyte development. Curr Opin Immunol 1997; 9:528.</a></li><li><a class="nounderline abstract_t">Wange RL, Samelson LE. Complex complexes: signaling at the TCR. Immunity 1996; 5:197.</a></li><li><a class="nounderline abstract_t">Kane LP, Lin J, Weiss A. Signal transduction by the TCR for antigen. Curr Opin Immunol 2000; 12:242.</a></li><li><a class="nounderline abstract_t">Qian D, Weiss A. T cell antigen receptor signal transduction. Curr Opin Cell Biol 1997; 9:205.</a></li><li><a class="nounderline abstract_t">van Leeuwen JE, Samelson LE. T cell antigen-receptor signal transduction. Curr Opin Immunol 1999; 11:242.</a></li><li><a class="nounderline abstract_t">van Oers NS. T cell receptor-mediated signs and signals governing T cell development. Semin Immunol 1999; 11:227.</a></li><li><a class="nounderline abstract_t">Zamoyska R, Basson A, Filby A, et al. The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation. Immunol Rev 2003; 191:107.</a></li><li><a class="nounderline abstract_t">Palacios EH, Weiss A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 2004; 23:7990.</a></li><li><a class="nounderline abstract_t">van Oers NS, Weiss A. The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes. Semin Immunol 1995; 7:227.</a></li><li><a class="nounderline abstract_t">Gauen LK, Zhu Y, Letourneur F, et al. Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif. Mol Cell Biol 1994; 14:3729.</a></li><li><a class="nounderline abstract_t">Irving BA, Chan AC, Weiss A. Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain. J Exp Med 1993; 177:1093.</a></li><li><a class="nounderline abstract_t">Iwashima M, Irving BA, van Oers NS, et al. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 1994; 263:1136.</a></li><li><a class="nounderline abstract_t">van Oers NS, Tohlen B, Malissen B, et al. The 21- and 23-kD forms of TCR zeta are generated by specific ITAM phosphorylations. Nat Immunol 2000; 1:322.</a></li><li><a class="nounderline abstract_t">Weil R, Cloutier JF, Fournel M, Veillette A. Regulation of Zap-70 by Src family tyrosine protein kinases in an antigen-specific T-cell line. J Biol Chem 1995; 270:2791.</a></li><li><a class="nounderline abstract_t">van Oers NS, Killeen N, Weiss A. Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes. J Exp Med 1996; 183:1053.</a></li><li><a class="nounderline abstract_t">Chan AC, Irving BA, Fraser JD, Weiss A. The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc Natl Acad Sci U S A 1991; 88:9166.</a></li><li><a class="nounderline abstract_t">Cohen S, Dadi H, Shaoul E, et al. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999; 93:2013.</a></li><li><a class="nounderline abstract_t">Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36:337.</a></li><li><a class="nounderline abstract_t">Wu H, Cantor RM, Graham DS, et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 2005; 52:2396.</a></li><li><a class="nounderline abstract_t">Vang T, Miletic AV, Bottini N, Mustelin T. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 2007; 40:453.</a></li><li><a class="nounderline abstract_t">Nahum A, Bates A, Sharfe N, Roifman CM. Association of the lymphoid protein tyrosine phosphatase, R620W variant, with chronic mucocutaneous candidiasis. J Allergy Clin Immunol 2008; 122:1220.</a></li><li><a class="nounderline abstract_t">Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 37:1317.</a></li><li><a class="nounderline abstract_t">Fiorillo E, Orrú V, Stanford SM, et al. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J Biol Chem 2010; 285:26506.</a></li><li><a class="nounderline abstract_t">Yasuda K, Nagafuku M, Shima T, et al. Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells. J Immunol 2002; 169:2813.</a></li><li><a class="nounderline abstract_t">Davidson D, Bakinowski M, Thomas ML, et al. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol Cell Biol 2003; 23:2017.</a></li><li><a class="nounderline abstract_t">Xu C, Gagnon E, Call ME, et al. Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif. Cell 2008; 135:702.</a></li><li><a class="nounderline abstract_t">Arpaia E, Shahar M, Dadi H, et al. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell 1994; 76:947.</a></li><li><a class="nounderline abstract_t">Elder ME, Lin D, Clever J, et al. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 1994; 264:1596.</a></li><li><a class="nounderline abstract_t">Roifman CM, Hummel D, Martinez-Valdez H, et al. Depletion of CD8+ cells in human thymic medulla results in selective immune deficiency. J Exp Med 1989; 170:2177.</a></li><li><a class="nounderline abstract_t">Roifman CM, Dadi H, Somech R, et al. Characterization of ζ-associated protein, 70 kd (ZAP70)-deficient human lymphocytes. J Allergy Clin Immunol 2010; 126:1226.</a></li><li><a class="nounderline abstract_t">Neumeister EN, Zhu Y, Richard S, et al. Binding of ZAP-70 to phosphorylated T-cell receptor zeta and eta enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins. Mol Cell Biol 1995; 15:3171.</a></li><li><a class="nounderline abstract_t">Wange RL, Malek SN, Desiderio S, Samelson LE. Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor zeta and CD3 epsilon from activated Jurkat T cells. J Biol Chem 1993; 268:19797.</a></li><li><a class="nounderline abstract_t">Isakov N, Wange RL, Burgess WH, et al. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity. J Exp Med 1995; 181:375.</a></li><li><a class="nounderline abstract_t">Hatada MH, Lu X, Laird ER, et al. Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature 1995; 377:32.</a></li><li><a class="nounderline abstract_t">Goldman FD, Ballas ZK, Schutte BC, et al. Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest 1998; 102:421.</a></li><li><a class="nounderline abstract_t">Chan AC, Dalton M, Johnson R, et al. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J 1995; 14:2499.</a></li><li><a class="nounderline abstract_t">Wange RL, Guitián R, Isakov N, et al. Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J Biol Chem 1995; 270:18730.</a></li><li><a class="nounderline abstract_t">Watts JD, Affolter M, Krebs DL, et al. Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70. J Biol Chem 1994; 269:29520.</a></li><li><a class="nounderline abstract_t">Kong G, Dalton M, Bubeck Wardenburg J, et al. Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function. Mol Cell Biol 1996; 16:5026.</a></li><li><a class="nounderline abstract_t">Gong Q, Jin X, Akk AM, et al. Requirement for tyrosine residues 315 and 319 within zeta chain-associated protein 70 for T cell development. J Exp Med 2001; 194:507.</a></li><li><a class="nounderline abstract_t">Katzav S, Sutherland M, Packham G, et al. The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. J Biol Chem 1994; 269:32579.</a></li><li><a class="nounderline abstract_t">Wu J, Zhao Q, Kurosaki T, Weiss A. The Vav binding site (Y315) in ZAP-70 is critical for antigen receptor-mediated signal transduction. J Exp Med 1997; 185:1877.</a></li><li><a class="nounderline abstract_t">Pelosi M, Di Bartolo V, Mounier V, et al. Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck. J Biol Chem 1999; 274:14229.</a></li><li><a class="nounderline abstract_t">Williams BL, Irvin BJ, Sutor SL, et al. Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation. EMBO J 1999; 18:1832.</a></li><li><a class="nounderline abstract_t">Di Bartolo V, Mège D, Germain V, et al. Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a critical role in T cell antigen receptor signaling. J Biol Chem 1999; 274:6285.</a></li><li><a class="nounderline abstract_t">Zhao Q, Weiss A. Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70. Mol Cell Biol 1996; 16:6765.</a></li><li><a class="nounderline abstract_t">Lupher ML Jr, Songyang Z, Shoelson SE, et al. The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. J Biol Chem 1997; 272:33140.</a></li><li><a class="nounderline abstract_t">Rao N, Lupher ML Jr, Ota S, et al. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells. J Immunol 2000; 164:4616.</a></li><li><a class="nounderline abstract_t">Rudd CE. Adaptors and molecular scaffolds in immune cell signaling. Cell 1999; 96:5.</a></li><li><a class="nounderline abstract_t">Bubeck Wardenburg J, Fu C, Jackman JK, et al. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J Biol Chem 1996; 271:19641.</a></li><li><a class="nounderline abstract_t">Finco TS, Kadlecek T, Zhang W, et al. LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway. Immunity 1998; 9:617.</a></li><li><a class="nounderline abstract_t">Yablonski D, Kuhne MR, Kadlecek T, Weiss A. Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell. Science 1998; 281:413.</a></li><li><a class="nounderline abstract_t">Yablonski D, Weiss A. Mechanisms of signaling by the hematopoietic-specific adaptor proteins, SLP-76 and LAT and their B cell counterpart, BLNK/SLP-65. Adv Immunol 2001; 79:93.</a></li><li><a class="nounderline abstract_t">Zhang W, Sloan-Lancaster J, Kitchen J, et al. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 1998; 92:83.</a></li><li><a class="nounderline abstract_t">Donovan JA, Wange RL, Langdon WY, Samelson LE. The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J Biol Chem 1994; 269:22921.</a></li><li><a class="nounderline abstract_t">June CH, Fletcher MC, Ledbetter JA, Samelson LE. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J Immunol 1990; 144:1591.</a></li><li><a class="nounderline abstract_t">Sommers CL, Samelson LE, Love PE. LAT: a T lymphocyte adapter protein that couples the antigen receptor to downstream signaling pathways. Bioessays 2004; 26:61.</a></li><li><a class="nounderline abstract_t">Raab M, da Silva AJ, Findell PR, Rudd CE. Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2. Immunity 1997; 6:155.</a></li><li><a class="nounderline abstract_t">Zhang W, Sommers CL, Burshtyn DN, et al. Essential role of LAT in T cell development. Immunity 1999; 10:323.</a></li><li><a class="nounderline abstract_t">Shen S, Zhu M, Lau J, et al. The essential role of LAT in thymocyte development during transition from the double-positive to single-positive stage. J Immunol 2009; 182:5596.</a></li><li><a class="nounderline abstract_t">Liao XC, Littman DR. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 1995; 3:757.</a></li><li><a class="nounderline abstract_t">Perez-Villar JJ, Kanner SB. Regulated association between the tyrosine kinase Emt/Itk/Tsk and phospholipase-C gamma 1 in human T lymphocytes. J Immunol 1999; 163:6435.</a></li><li><a class="nounderline abstract_t">Mano H. Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine Growth Factor Rev 1999; 10:267.</a></li><li><a class="nounderline abstract_t">Bogin Y, Ainey C, Beach D, Yablonski D. SLP-76 mediates and maintains activation of the Tec family kinase ITK via the T cell antigen receptor-induced association between SLP-76 and ITK. Proc Natl Acad Sci U S A 2007; 104:6638.</a></li><li><a class="nounderline abstract_t">Qi Q, August A. Keeping the (kinase) party going: SLP-76 and ITK dance to the beat. Sci STKE 2007; 2007:pe39.</a></li><li><a class="nounderline abstract_t">Juntilla MM, Koretzky GA. Critical roles of the PI3K/Akt signaling pathway in T cell development. Immunol Lett 2008; 116:104.</a></li><li><a class="nounderline abstract_t">Kane LP, Weiss A. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol Rev 2003; 192:7.</a></li><li><a class="nounderline abstract_t">Ebanks R, Roifman C, Mellors A, Mills GB. The diacylglycerol analogue, 1,2-sn-dioctanoylglycerol, induces an increase in cytosolic free Ca2+ and cytosolic acidification of T lymphocytes through a protein kinase C-independent process. Biochem J 1989; 258:689.</a></li><li><a class="nounderline abstract_t">Beyersdorf N, Braun A, Vögtle T, et al. STIM1-independent T cell development and effector function in vivo. J Immunol 2009; 182:3390.</a></li><li><a class="nounderline abstract_t">Melamed I, Stein L, Roifman CM. Epstein-Barr virus induces actin polymerization in human B cells. J Immunol 1994; 153:1998.</a></li><li><a class="nounderline abstract_t">Dustin ML, Chakraborty AK, Shaw AS. Understanding the structure and function of the immunological synapse. Cold Spring Harb Perspect Biol 2010; 2:a002311.</a></li><li><a class="nounderline abstract_t">Dustin ML. Modular design of immunological synapses and kinapses. Cold Spring Harb Perspect Biol 2009; 1:a002873.</a></li><li><a class="nounderline abstract_t">Fooksman DR, Vardhana S, Vasiliver-Shamis G, et al. Functional anatomy of T cell activation and synapse formation. Annu Rev Immunol 2010; 28:79.</a></li><li><a class="nounderline abstract_t">Sims TN, Soos TJ, Xenias HS, et al. Opposing effects of PKCtheta and WASp on symmetry breaking and relocation of the immunological synapse. Cell 2007; 129:773.</a></li><li><a class="nounderline abstract_t">Sykulev Y. T cell receptor signaling kinetics takes the stage. Sci Signal 2010; 3:pe50.</a></li><li><a class="nounderline abstract_t">Villa A, Santagata S, Bozzi F, et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998; 93:885.</a></li><li><a class="nounderline abstract_t">Brockmeyer C, Paster W, Pepper D, et al. T cell receptor (TCR)-induced tyrosine phosphorylation dynamics identifies THEMIS as a new TCR signalosome component. J Biol Chem 2011; 286:7535.</a></li><li><a class="nounderline abstract_t">Colucci F, Schweighoffer E, Tomasello E, et al. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat Immunol 2002; 3:288.</a></li><li><a class="nounderline abstract_t">Palacios EH, Weiss A. Distinct roles for Syk and ZAP-70 during early thymocyte development. J Exp Med 2007; 204:1703.</a></li><li><a class="nounderline abstract_t">Chu DH, van Oers NS, Malissen M, et al. Pre-T cell receptor signals are responsible for the down-regulation of Syk protein tyrosine kinase expression. J Immunol 1999; 163:2610.</a></li><li><a class="nounderline abstract_t">Elder ME, Skoda-Smith S, Kadlecek TA, et al. Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. J Immunol 2001; 166:656.</a></li><li><a class="nounderline abstract_t">Wiest DL, Ashe JM, Howcroft TK, et al. A spontaneously arising mutation in the DLAARN motif of murine ZAP-70 abrogates kinase activity and arrests thymocyte development. Immunity 1997; 6:663.</a></li><li><a class="nounderline abstract_t">Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature 1999; 402:255.</a></li><li><a class="nounderline abstract_t">Anderson MS, Su MA. Aire and T cell development. Curr Opin Immunol 2011; 23:198.</a></li><li><a class="nounderline abstract_t">Akirav EM, Ruddle NH, Herold KC. The role of AIRE in human autoimmune disease. Nat Rev Endocrinol 2011; 7:25.</a></li><li><a class="nounderline abstract_t">Chan AC, van Oers NS, Tran A, et al. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol 1994; 152:4758.</a></li><li><a class="nounderline abstract_t">Williams BL, Schreiber KL, Zhang W, et al. Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol Cell Biol 1998; 18:1388.</a></li><li><a class="nounderline abstract_t">Noraz N, Schwarz K, Steinberg M, et al. Alternative antigen receptor (TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high levels of Syk. J Biol Chem 2000; 275:15832.</a></li><li><a class="nounderline abstract_t">Toyabe S, Watanabe A, Harada W, et al. Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling. Immunology 2001; 103:164.</a></li><li><a class="nounderline abstract_t">Cheng AM, Negishi I, Anderson SJ, et al. The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated in pre-T cell receptor signaling. Proc Natl Acad Sci U S A 1997; 94:9797.</a></li><li><a class="nounderline abstract_t">Lesourne R, Uehara S, Lee J, et al. Themis, a T cell-specific protein important for late thymocyte development. Nat Immunol 2009; 10:840.</a></li><li><a class="nounderline abstract_t">Fu G, Vallée S, Rybakin V, et al. Themis controls thymocyte selection through regulation of T cell antigen receptor-mediated signaling. Nat Immunol 2009; 10:848.</a></li><li><a class="nounderline abstract_t">Brumbaugh KM, Binstadt BA, Billadeau DD, et al. Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J Exp Med 1997; 186:1965.</a></li><li><a class="nounderline abstract_t">Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1:41.</a></li><li><a class="nounderline abstract_t">Elder ME, Hope TJ, Parslow TG, et al. Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency. Cell Immunol 1995; 165:110.</a></li><li><a class="nounderline abstract_t">Morris AB, Adams LE, Ford ML. Influence of T Cell Coinhibitory Molecules on CD8+ Recall Responses. Front Immunol 2018; 9:1810.</a></li></ol></div><div id="topicVersionRevision">Topic 15794 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20516133" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : ITAM-mediated signaling by the T-cell antigen receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15057788" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Jurkat T cells and development of the T-cell receptor signalling paradigm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15084594" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : T cell receptor signaling: beyond complex complexes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27712102" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : TCR Signal Strength and T Cell Development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28923982" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34897277" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : T cell receptor (TCR) signaling in health and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8293463" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Signal transduction by lymphocyte antigen receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9287188" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Protein tyrosine kinases in thymocyte development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8808675" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Complex complexes: signaling at the TCR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10781399" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Signal transduction by the TCR for antigen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9069257" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : T cell antigen receptor signal transduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10375551" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : T cell antigen-receptor signal transduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10441209" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : T cell receptor-mediated signs and signals governing T cell development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12614355" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15489916" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8520027" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8196616" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8459204" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7509083" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11017104" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The 21- and 23-kD forms of TCR zeta are generated by specific ITAM phosphorylations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7852351" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Regulation of Zap-70 by Src family tyrosine protein kinases in an antigen-specific T-cell line.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8642247" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1717999" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10068674" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15004560" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16052563" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17729039" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Protein tyrosine phosphatase PTPN22 in human autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19084113" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Association of the lymphoid protein tyrosine phosphatase, R620W variant, with chronic mucocutaneous candidiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16273109" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20538612" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12218089" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12612075" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19013279" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8124727" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8202712" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2511270" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Depletion of CD8+ cells in human thymic medulla results in selective immune deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20864151" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Characterization ofζ-associated protein, 70 kd (ZAP70)-deficient human lymphocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7760813" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Binding of ZAP-70 to phosphorylated T-cell receptor zeta and eta enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8366117" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor zeta and CD3 epsilon from activated Jurkat T cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7528772" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7659156" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9664084" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Defective expression of p56lck in an infant with severe combined immunodeficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7781602" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7642520" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7961936" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8756661" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11514606" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Requirement for tyrosine residues 315 and 319 within zeta chain-associated protein 70 for T cell development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7798261" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9151714" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The Vav binding site (Y315) in ZAP-70 is critical for antigen receptor-mediated signal transduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10318843" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10202147" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10037717" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a critical role in T cell antigen receptor signaling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8943331" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9407100" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10779765" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9989491" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Adaptors and molecular scaffolds in immune cell signaling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8702662" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9846483" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9665884" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11680012" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Mechanisms of signaling by the hematopoietic-specific adaptor proteins, SLP-76 and LAT and their B cell counterpart, BLNK/SLP-65.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9489702" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8083187" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1689750" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14696041" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : LAT: a T lymphocyte adapter protein that couples the antigen receptor to downstream signaling pathways.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9047237" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10204488" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Essential role of LAT in T cell development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19380807" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The essential role of LAT in thymocyte development during transition from the double-positive to single-positive stage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8777721" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10586033" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Regulated association between the tyrosine kinase Emt/Itk/Tsk and phospholipase-C gamma 1 in human T lymphocytes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10647781" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Tec family of protein-tyrosine kinases: an overview of their structure and function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17420479" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : SLP-76 mediates and maintains activation of the Tec family kinase ITK via the T cell antigen receptor-induced association between SLP-76 and ITK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17652306" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Keeping the (kinase) party going: SLP-76 and ITK dance to the beat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18243340" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Critical roles of the PI3K/Akt signaling pathway in T cell development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12670391" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2786413" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : The diacylglycerol analogue, 1,2-sn-dioctanoylglycerol, induces an increase in cytosolic free Ca2+ and cytosolic acidification of T lymphocytes through a protein kinase C-independent process.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19265116" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : STIM1-independent T cell development and effector function in vivo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8051404" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Epstein-Barr virus induces actin polymerization in human B cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20843980" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Understanding the structure and function of the immunological synapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20066081" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Modular design of immunological synapses and kinapses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19968559" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Functional anatomy of T cell activation and synapse formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17512410" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Opposing effects of PKCtheta and WASp on symmetry breaking and relocation of the immunological synapse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21177491" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : T cell receptor signaling kinetics takes the stage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9630231" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Partial V(D)J recombination activity leads to Omenn syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21189249" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : T cell receptor (TCR)-induced tyrosine phosphorylation dynamics identifies THEMIS as a new TCR signalosome component.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11836527" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17606633" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Distinct roles for Syk and ZAP-70 during early thymocyte development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10453000" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Pre-T cell receptor signals are responsible for the down-regulation of Syk protein tyrosine kinase expression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11123350" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9208839" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : A spontaneously arising mutation in the DLAARN motif of murine ZAP-70 abrogates kinase activity and arrests thymocyte development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10580495" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Selecting and maintaining a diverse T-cell repertoire.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21163636" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Aire and T cell development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21102544" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The role of AIRE in human autoimmune disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8176201" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9488454" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10748099" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Alternative antigen receptor (TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high levels of Syk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11412303" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9275205" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : The Syk and ZAP-70 SH2-containing tyrosine kinases are implicated in pre-T cell receptor signaling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19597498" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Themis, a T cell-specific protein important for late thymocyte development.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19597499" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Themis controls thymocyte selection through regulation of T cell antigen receptor-mediated signaling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9396765" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11905813" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Natural killer cells, viruses and cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7671314" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30135685" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Influence of T Cell Coinhibitory Molecules on CD8+ Recall Responses.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
